| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8241965 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
Conclusions: Intermittent androgen suppression appears to be a favorable treatment option for patients with biochemically (according to level of PSA) or locally recurrent prostate cancer with favorable long-term survival, a high probability of eligibility for OTIs, and durable OTIs.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shawn M.D., Gad M.D., Libni M.D., Roanne M.D., Victor M.A., Simone Ph.D., Juanita M.D., Johanna N. M.Sc.,